The U.S. Food and Drug Administration has approved Zoryve (roflumilast) topical foam 0.3 percent for the treatment of plaque ...

The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque psoriasis of the scalp and ...

“In general, I’m not a fan of spray sunscreens but they do play a huge role when it comes to scalp protection because it’s difficult to apply a cream to that area,” says Young. “Just ...

In that research review, the authors noted that it appears to be the first of its kind looking specifically at the connection between Candida and psoriasis. Still, more research is needed on the ...